AC
Armistice Capital Portfolio holdings
AUM
$2.64B
This Quarter Return
+4.88%
1 Year Return
+0.99%
3 Year Return
+16.29%
5 Year Return
+18.04%
10 Year Return
+34.8%
AUM
$3.82B
AUM Growth
+$1.18M
(+0.03%)
Cap. Flow
-$187M
Cap. Flow
% of AUM
-4.89%
Top 10 Holdings %
Top 10 Hldgs %
31.93%
Holding
328
New
76
Increased
87
Reduced
63
Closed
72
Top Buys
| 1 |
NARI
Inari Medical, Inc. Common Stock
NARI
|
$33.5M |
| 2 |
FIVE9
FIVN
|
$33.1M |
| 3 |
Domino's
DPZ
|
$32.9M |
| 4 |
Incyte
INCY
|
$28.6M |
| 5 |
Humana
HUM
|
$23.6M |
Top Sells
| 1 |
Neurocrine Biosciences
NBIX
|
$91.8M |
| 2 |
Exact Sciences
EXAS
|
$59.2M |
| 3 |
Sanofi
SNY
|
$53M |
| 4 |
Keurig Dr Pepper
KDP
|
$49.6M |
| 5 |
GSK
GSK
|
$39.9M |
Sector Composition
| 1 | Healthcare | 68.01% |
| 2 | Consumer Discretionary | 11.66% |
| 3 | Consumer Staples | 8.76% |
| 4 | Technology | 8.5% |
| 5 | Communication Services | 1.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
AngioDynamics
ANGO
$432M
| $7.48M | 0.12% |
962,000
+126,000
| +15% | +$980K |
|
102
Alcon
ALC
$38.9B
| $7.08M | 0.11% |
+70,740
| New | +$7.08M |
|
103
Target
TGT
$42B
| $7.07M | 0.11% |
45,373
-21,146
| -32% | -$3.3M |
|
104
Smith & Nephew
SNN
$16.2B
| $6.98M | 0.11% |
+224,000
| New | +$6.98M |
|
|
GB
105
DELISTED
Global Blue Group Holding
GB
| $6.64M | 0.11% |
1,214,475
| – | – |
|
106
Nomad Foods
NOMD
$2.31B
| $6.5M | 0.1% |
+340,913
| New | +$6.5M |
|
107
UiPath
PATH
$5.82B
| $6.28M | 0.1% |
490,615
-235,905
| -32% | -$3.02M |
|
108
Zura Bio
ZURA
$132M
| $6.09M | 0.1% |
1,500,000
-1,024,000
| -41% | -$4.16M |
|
109
Eledon Pharmaceuticals
ELDN
$155M
| $5.89M | 0.09% |
2,364,000
+28,000
| +1% | +$69.7K |
|
110
CervoMed
CRVO
$93M
| $5.87M | 0.09% |
402,000
-238,000
| -37% | -$3.47M |
|
111
Evolus
EOLS
$477M
| $5.83M | 0.09% |
360,000
| – | – |
|
112
Axogen
AXGN
$718M
| $5.61M | 0.09% |
+400,055
| New | +$5.61M |
|
113
Rani Therapeutics
RANI
$23.2M
| $5.56M | 0.09% |
+2,574,000
| New | +$5.56M |
|
114
Crocs
CROX
$4.74B
| $5.52M | 0.09% |
+38,130
| New | +$5.52M |
|
115
VolitionRX
VNRX
$71.6M
| $5.41M | 0.09% |
+8,998,727
| New | +$5.41M |
|
116
Assembly Biosciences
ASMB
$185M
| $5.36M | 0.09% |
354,000
-114,000
| -24% | -$1.73M |
|
|
GOOS
117
Canada Goose Holdings
GOOS
$1.28B
| $5.35M | 0.09% |
427,000
+92,000
| +27% | +$1.15M |
|
118
Mural Oncology
MURA
$35.9M
| $5.32M | 0.09% |
1,700,000
+12,000
| +0.7% | +$37.6K |
|
119
Etsy
ETSY
$5.15B
| $5.01M | 0.08% |
+90,164
| New | +$5.01M |
|
120
Bloomin' Brands
BLMN
$595M
| $4.96M | 0.08% |
300,000
+175,000
| +140% | +$2.89M |
|
|
DNMR
121
DELISTED
Danimer Scientific, Inc.
DNMR
| $4.9M | 0.08% |
269,700
+9,100
| +3% | +$165K |
|
122
BJ's Restaurants
BJRI
$749M
| $4.88M | 0.08% |
150,000
+75,000
| +100% | +$2.44M |
|
123
Allurion Technologies
ALUR
$16.5M
| $4.79M | 0.08% |
+312,240
| New | +$4.79M |
|
124
Boston Scientific
BSX
$159B
| $4.76M | 0.08% |
56,855
+33,555
| +144% | +$2.81M |
|
125
Reviva Pharmaceuticals
RVPH
$31.3M
| $4.59M | 0.07% |
+3,186,000
| New | +$4.59M |
|